Serious Conceal
Natural health product licensed in Canada
- Licence holder
- Flageoli, Ltd.
- NPN or DIN-HM
- 80004330
- Status
- Inactive licence
- Licence date
- 25 October 2007
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Laneth-16, Dioxyde de titane, Parahydroxybenzoate de méthyle, Palmitate de cétyle, Octyldodecanol, Acide citrique, Eau, Stéarate de glycéryle, Oxydes de fer, Oxyde de zinc, Diméthicone, Alcool cétylique, Oleth-16, Stéareth-16, (p)-hydroxybenzoate de propyle, Imidazolidinyl urea, Stéarate de PEG-100, Silicate d'aluminium et de magnésium, Ceteth-16
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Dries and helps clear up acne pimples. Helps prevent new acne pimples form forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Using other topical acne products at the same time to immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one product should be used unless directed by a health care practitioner. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. Discontinue use if excessive skin irritation develops or increases. If irritation persists, consult a health care practitioner.
Source
Official Health Canada record, licence 80004330
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.